BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2145325)

  • 1. Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal.
    Job CK; Yoder L; Jacobson RR; Hastings RC
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):236-41. PubMed ID: 2145325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
    McDougall AC; Jones RL
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):116-20. PubMed ID: 6260900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual cause of small-intestine mucosal pigmentation.
    Raftopoulos SC; Fermoyle S
    Gastrointest Endosc; 2011 Jun; 73(6):1285-6. PubMed ID: 21354567
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 5. Autofluorescence of clofazimine in discoid lupus erythematosus.
    Kossard S; Doherty E; McColl I; Ryman W
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 2):867-71. PubMed ID: 3680675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polychromatic corneal and conjunctival crystals secondary to clofazimine therapy in a leper.
    Font RL; Sobol W; Matoba A
    Ophthalmology; 1989 Mar; 96(3):311-5. PubMed ID: 2710521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
    Sakurai I; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.
    Oommen ST; Natu MV; Mahajan MK; Kadyan RS
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):32-6. PubMed ID: 8189086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of clofazimine in human milk in leprosy patients.
    Venkatesan K; Mathur A; Girdhar A; Girdhar BK
    Lepr Rev; 1997 Sep; 68(3):242-6. PubMed ID: 9364825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofazimine induced nail changes.
    Dixit VB; Chaudhary SD; Jain VK
    Indian J Lepr; 1989 Oct; 61(4):476-8. PubMed ID: 2621382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lepromatous leprosy with drug reaction.
    Baxt RD
    Dermatol Online J; 2000 Sep; 6(1):9. PubMed ID: 11328619
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of side-effects experienced by patients taking clofazimine.
    Moore VJ
    Lepr Rev; 1983 Dec; 54(4):327-35. PubMed ID: 6668986
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
    Browne SG; Harman DJ; Waudby H; McDougall AC
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of dermatological conditions in leprosy in-patients.
    Patki AH; Jadhav VH; Mehta JM
    Indian J Lepr; 1989 Jan; 61(1):92-5. PubMed ID: 2522976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.